CHOICE study: Relative hazard of ASCVD events by baseline levels of Lp(a), LMW ApoA isoforms, and LMW ApoA isoforms with high Lp(a) vs high-molecular-weight.

Slides:

Advertisements

Similar presentations

Introduction Lipoprotein(a) [Lp(a)]

Advertisements

Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;

Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:

M 7.0, M L M 6.9, M L 6.99.

The AURORA Trial Source: Holdaas H, Holme I, Schmieder RE, et al. Rosuvastatin in diabetic hemodialysis patient. J Am Soc Nephrol. 2011;22(7):1335–1341.

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

Arterioscler Thromb Vasc Biol

TNT: Baseline and final LDL cholesterol levels

Tips Need to Consider When Organizing a College Event

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

CHOICE: Relative risk of death on peritoneal dialysis vs hemodialysis

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Kuwabara et al. Am J Nephrol 2017;45: (DOI: / )

Atorvastatin 20 mg (n=25 lesions) Atorvastatin 5 mg (n=25 lesions)

Mean BP from initial visit to four years

Outcomes with trisodium citrate 30% vs heparin as catheter-locking solution (all catheters) in patients on hemodialysis Variable TSC, n (%) Heparin, n.

Sequence alignment of C-terminal phosphorylated plant aquaporins

Baseline characteristics of patients

Effect of evolocumab on lipoprotein particles

Bushinsky et al. Am J Nephrol 2016;44: (DOI: / )

ماجستير إدارة المعارض من بريطانيا

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Volume 66, Issue 1, Pages (July 2004)

Management of hypertension in patients with chronic kidney disease

Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study Burst et al. Am J Nephrol 2017;45:

Volume 55, Issue 2, Pages (February 1999)

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.

Relative risk of major events with atenolol vs placebo

Health ABC: Mortality risk by quintile of cystatin C

Figure 1 Changes in relative plasma volume (RPV)

Volume 62, Issue 2, Pages (August 2002)

BRAVO-3 Trial design: Patients undergoing transfemoral TAVR were randomized in a 1:1 fashion to bivalirudin or UFH. They were followed for 30 days. Results.

Figure 3 Serum phosphate level is associated with

Line graph showing change in size over time relative to baseline CT

CKD cohort Non-CKD cohort Test Entire cohort, n=24 778

Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.

Predictors of disease progression in patients with CKD

Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects Akizawa et.

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Mean concentrations (mM) of PG1+2, PG3 and PG4+5 in patients with or without MTX-related toxicity at baseline, week 4 and week 24/26 in (A) CONCERTO and.

Nat. Rev. Nephrol. doi: /nrneph

Volume 56, Issue 3, Pages (September 1999)

Baseline Characteristics by Baseline N-BNP Level

Patient characteristics: American vs Canadian transplant patients

Differential expression of apoA-I and Vimentin on 2D gels

Baseline Characteristics of the Subjects

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Patient Disposition James A. de Lemos et al. JAMA 2004; 292:

Baseline Characteristics of Study Populations

Sotirios Tsimikas JACC 2017;69:

(p for noninferiority = 0.01)

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis.

Standard mean difference of change in creatinine between the intravenous (IV) versus oral (PO) arm. Standard mean difference of change in creatinine between.

Adjusted relative risk Adjusted odds ratio

(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. (A) Energy and (B) protein intake/day during hospitalisation and in follow-up.

Acta Pathol Microbiol Scand and Clin Lab Med use in PPT for external audience verified via Rightsphere 25Jul

Flow of study participants

Intracerebroventricular (ICV) insulin infusion increases TG secretion.

Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund

A and B, mRNA expression relative to ERα (in%) for ZNF423 (A) and BRCA1 (B) for LCLs of known genotypes for variant (V) and WT chromosome 16 ZNF423 SNPs.

Src expression in a panel of human TCC cell lines.

Incidences of transitions between glycemic states by 25-OHD level.

Graphical representation of the conditional model 2

Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.

Plasma metformin concentrations and bioavailability after administration of a single daily dose (study 1). Plasma metformin concentrations and bioavailability.

Avasare et al. Am J Nephrol 2017;45:99-106 (DOI: / )

Presentation transcript:

CHOICE study: Relative hazard of ASCVD events by baseline levels of Lp(a), LMW ApoA isoforms, and LMW ApoA isoforms with high Lp(a) vs high-molecular-weight ApoA and low levels of Lp(a) Measure Relative hazard p High Lp(a) concentration (>53 nmol/L vs <53 nmol/L) 1.38 0.02 LMW ApoA isoforms (<22 K-IV repeats vs >22 K-IV repeats) 1.58 <0.0005 LMW ApoA and Lp(a) level >123 nmol/L vs high-molecular-weight ApoA and Lp(a) level <123 nmol/L 1.73 Longenecker JC et al. J Am Soc Nephrol 2005; available at: http://www.jasn.org.